Quantcast

Latest Pandemics Stories

2014-09-05 08:22:57

BEIJING, Sept. 5, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced a new presentation time for the Aegis Healthcare & Technology Conference, to be held at the Wynn Las Vegas on September 12, 2014. Management will present at 8:00 am PT. Please contact your Aegis representative to schedule a meeting with the Company. About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical company that...

2014-09-02 08:28:32

BEIJING, Sept. 2, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company's management will participate in the following investor conferences in September: -- Morgan Stanley Global Healthcare Conference, to be held at the Grand Hyatt New York on September 9 and 10, 2014. -- Morgan Stanley Asia Pacific Healthcare Day, to be held at the Boston Harbor Hotel on September 11,...

2014-08-27 08:26:54

BEIJING, Aug. 27, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2014 Annual General Meeting of Shareholders held on Wednesday, August 27, 2014 in Beijing, PRC. The required quorum, a majority of the common shares outstanding, was voted by proxy. The Company's shareholders approved the following proposals: -- The re-election of Weidong Yin, Yuk Lam Lo, Simon Anderson,...

2014-08-26 16:28:01

New Analysis Provides Basis for a Synthetic Influenza H1N1 Blocker-Vaccine Candidate, Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Influenza H1N1 virus strains has revealed extensive conservation and sharing of specific Replikin structures back to 1918. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Influenza H1N1...

2014-08-16 23:00:48

MarketReportsOnline.com adds "Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)" report to its research store. Dallas, Texas (PRWEB) August 16, 2014 With the advancement in technology and discovery of new products in the field of medical sciences, vaccines have gained crucial position in the pharmaceutical industry. Vaccines are considered as the most effective health intervention ever developed, saving innumerable lives. The vaccine market is growing...

flu shot for seniors
2014-08-15 03:13:00

Craig Boerner, Vanderbilt University High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications, according to a Vanderbilt-led study published this week in the New England Journal of Medicine (NEJM). The multi-center study enrolled 31,989 participants from 126 research centers in the U.S. and Canada during the 2011-2012 and 2012-2013 influenza seasons in the Northern...

2014-08-12 23:03:06

The North American Swine Feed & Feed Additives Market report defines and segments the swine feed & feed additives market in North America with analysis and forecast of revenue. http://www.micromarketmonitor.com/market/north-america-swine-feed-2493779511.html (PRWEB) August 12, 2014 The North American Swine Feed & Feed Additives Market report defines and segments the swine feed & feed additives market in North America with analysis and forecast of revenue. The swine feed...

2014-08-05 23:04:14

GIA announces the release of a comprehensive global report on Hand Sanitizers markets. Global market for Hand Sanitizers is projected to reach US$1.6 billion by 2020, driven by rising awareness about health and hygiene and focus on prevention of infectious diseases. San Jose, California (PRWEB) August 05, 2014 Follow us on LinkedIn – Hand sanitizers are disinfectants that offer effective protection against harmful pathogens. The focus on preventing transmission of diseases through...

2014-07-30 12:30:26

LONDON, July 30, 2014 /PRNewswire/ -- Replikins Ltd. today released new data on changes in the gene structure of the Ebola virus. Before the current outbreaks, the mean Ebola Reston gene Replikin Count (number of Replikins per 100 amino acids) between 1995 and 2002 was 1.1; the mean Replikin Count increased twofold in 2010, threefold in 2012, and sixteen-fold in 2013, thus predicting the current outbreaks in humans. In the past, this technology has been shown to be able to predict...

2014-07-29 23:02:52

World renown public health professional, Ronald St. John, creates Sitata. A company which provides world travellers with up-to-date safety and health alerts, status of epidemics worldwide, and suggestions on vaccinations and related symptoms of diseases identified as of possible risk to travellers. Toronto, Canada (PRWEB) July 29, 2014 Sitata provides world travellers with up-to-date safety and health alerts, status of epidemics worldwide, and suggestions on vaccinations and related...


Latest Pandemics Reference Libraries

72_f634c1b2916580c60814457a175ea810
2011-04-28 15:06:23

Vibrio cholerae is a gram negative comma-shaped bacterium with a polar flagellum that causes cholera in humans. V. cholerae belongs to the gamma subdivision of the Proteobacteria. Classical and El Tor are the two types of V. Cholerae identified by hemaggluttination testing. El Tor is found throughout the world, while the classical biotype is found only in Bangladesh. It was first isolated as the cause of cholera by Italian anatomist Filippo Pacini in 1854; however, this discovery was not...

More Articles (1 articles) »
Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.